Primary prophylaxis for venous thromboembolism in ambulatory cancer patients: a systematic review and network meta-analysis | Zendy

Zechang Xin | Zendy; Fei Liu | Zendy; Yan Ping Du | Zendy; Feiyu Mao | Zendy; Xiaodong Wang | Zendy; Peng Xu | Zendy; Zhennan Li | Zendy; Jianjun Qian | Zendy; Jie Yao | Zendy

Open Access

Primary prophylaxis for venous thromboembolism in ambulatory cancer patients: a systematic review and network meta-analysis

Author(s) -

Zechang Xin,

Fei Liu,

Yan Ping Du,

Feiyu Mao,

Xiaodong Wang,

Peng Xu,

Zhennan Li,

Jianjun Qian,

Jie Yao

Publication year - 2020

Publication title -

annals of palliative medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.546

H-Index - 19

eISSN - 2224-5839

pISSN - 2224-5820

DOI - 10.21037/apm-20-47

Subject(s) - medicine , apixaban , meta analysis , warfarin , ambulatory , odds ratio , randomized controlled trial , rivaroxaban , stroke (engine) , aspirin , surgery , atrial fibrillation , mechanical engineering , engineering

Ambulatory cancer patients carry a high risk of venous thromboembolism (VTE). However, the optimal prophylaxis strategy remains controversial. This meta-analysis compared the effectiveness and safety of apixaban, rivaroxaban, low molecular weight heparin (LMWH), semuloparin, aspirin, and warfarin for the prevention of VTE in ambulatory cancer patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research